Related Experiment Video
Updated: Jun 30, 2026

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
TCF7L2 expression in diabetic patients undergoing bariatric surgery
A Katharine Hindle1, Fred Brody, Rahul Tevar
1Department of Surgery, The George Washington University Medical Center, Washington, DC, USA.
Surgical Endoscopy
|September 23, 2008
Summary
This study found that Transcription Factor 7-Like 2 (TCF7L2) gene expression differs in morbidly obese patients with diabetes. TCF7L2 expression correlates inversely with BMI in diabetic patients, unlike in nondiabetic patients.
Area of Science:
- Genetics and Molecular Biology
- Endocrinology and Metabolism
- Bariatric Surgery Research
Background:
- Diabetes in morbidly obese patients is multifactorial, involving genetic, social, and dietary factors.
- Transcription Factor 7-Like 2 (TCF7L2) is implicated in diabetes development.
- This study investigates TCF7L2 expression in liver tissue of morbidly obese individuals.
Purpose of the Study:
- To examine TCF7L2 gene expression in liver samples from morbidly obese patients.
- To compare TCF7L2 expression between diabetic and nondiabetic individuals within this cohort.
- To explore correlations between TCF7L2 expression, BMI, and glycemic control.
Main Methods:
- Liver tissue samples were collected from 20 morbidly obese patients undergoing bariatric surgery.
- RNA was extracted, and cDNA was synthesized for quantitative polymerase chain reaction (qPCR) analysis of TCF7L2 expression.
- Univariate analysis and logistic regression were used to correlate demographic and gene expression data.
Main Results:
- No overall correlation between BMI and TCF7L2 expression was observed in the entire group.
- A positive correlation between TCF7L2 expression and BMI was found in nondiabetic patients (R²=0.21).
- An inverse correlation between TCF7L2 expression and BMI was observed in diabetic patients (R²=0.58).
Conclusions:
- TCF7L2 gene expression is associated with type 2 diabetes in morbidly obese patients.
- The relationship between TCF7L2 expression and BMI differs between diabetic and nondiabetic individuals.
- These findings contribute to understanding the genetic underpinnings of diabetes in obesity.
Related Concept Videos
Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

